Recon: Swissmedic begins rolling review of Moderna COVID vaccine; COVAX raises $2B

• US government partners with pharmacy chains to increase COVID-19 vaccine access (Reuters)
• An FDA adviser on why his panel took a skeptical view on Biogen’s Alzheimer’s drug (STAT)
• Indivior hit with $600 million in civil and criminal penalties over marketing of opioid addiction treatment (The Hill) (DoJ)
• Labs sound alarm on coronavirus testing capacity, supplies (Politico)
• Vaccine alliance expects to hold talks with Biden team on COVAX (Reuters)

• Switzerland starts 'rolling review' of Moderna COVID-19 vaccine (Reuters)
• Vaccine alliance secures $2 billion to fund COVID shots for poor nations (Reuters)
• World's top intensive care body advises against remdesivir for sickest COVID patients (Reuters)
• Indonesia to start mass COVID-19 vaccination this year (Reuters)
• Canada bets on imports as home-grown COVID-19 vaccine heads to large-scale trials (Reuters)
• Israel signs deal with Pfizer for potential COVID-19 vaccine (Reuters)
• Australian COVID-19 vaccine candidate produces antibody response in early tests (Reuters)
• Pfizer in talks with Brazil to supply COVID-19 vaccine by early 2021 (Reuters)
• Measles Deaths Soared Worldwide Last Year, as Vaccine Rates Stalled (NYTimes)

• Covid vaccine presents pharma with shot at redemption and profits (FT)
• Until a Vaccine Arrives, a Worrisome Road Ahead (NYTimes)
• No Brexit delays for UK vaccine imports, minister says (Reuters)
• EU May Disclose Some Details Of COVID-19 Vaccine Contracts (Pink Sheet)
• China approves Shanghai Fosun's unit to run human testing for BioNTech's COVID-19 vaccine (Reuters)
• South Korean firm to produce 150 mln doses a year of Russian COVID-19 vaccine: RDIF (Reuters)
• Spain's Reig Jofre to have capacity for 50 million COVID-19 vaccine doses a year (Reuters)
• Relief Therapeutics says 150 enrolled in COVID drug trial (Reuters)
• Qiagen seeks EUA for COVID-19 antigen test aiming for positive results in 2 minutes (MedtechDive)
• Pill used to treat OCD and anxiety may prevent Covid-19 from worsening, a preliminary study suggests (STAT)
• Interferon beta-1a candidate for COPD advances to PhIII to test its potential against Covid-19 (Endpoints)

• Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone (Endpoints)
• BioMarin CEO Bienaimé beats a retreat from Europe, yanking their application for hemophilia A gene therapy (Endpoints)
• For COVID Drugs, Months of Frantic Development Lead to Few Outright Successes (Scientific American)
• New Powers For EMA Under EU ‘Future Proofing’ Plans (Pink Sheet)
• NICE green light for Cablivi in rare blood-clotting disorder (PharmaTimes)
• Regulators Find Room For ICH Q3D Metal Impurity Risk Assessments To Improve (Pink Sheet)
• Australian Industry Maps Path To Better Use Of Real World Evidence (Pink Sheet)
• As the curtain closes on the Trump presidency, biotech wrestles with its future in a divided America (Endpoints)
• California voters approve another round of funding for stem cell research (STAT)
• No thanks: Roche backs out of EGFR-related protein degraders in revised deal with C4 (Endpoints)
• Shanghai Junshi delays drug trials, focuses on COVID-19 treatment (Reuters)
• Healthcare group Sanofi invests 50 million euros in Jeito Capital (Reuters)
• Cancer clinical trial enrollment has plummeted. Will patients come back amid Covid-19? (STAT)
• The ‘prescription escalator’ may be to blame for rising out-of-pocket drug spending (STAT)
• After Novo Nordisk's acquisition of Corvidia, Ram Aiyar takes the helm at Korro Bio; Silverback gets a new CFO to go along with its IPO (Endpoints)
• Seer heads to Nasdaq with $150M IPO; IN8bio postpones public debut amid record year on Wall Street (Endpoints)

• 3 ways Biden's COVID-19 approach could impact medtech (MedtechDive)
• Medtronic launches connected smart insulin pen gained in Companion Medical deal (Fierce)
• Cook Medical Recalls Fixed Core Wire Guides, Due to Device Damage from a Manufacturing Error (FDA)
• Dialysis device maker Outset Medical tops revenue targets in first quarter since IPO (MedtechDive)

• PTAB Mylan Decision Could Be Boon To Drug Innovators (Law360)
• Pfizer Unit Hit With Another Suit Over Tossed Lyrica Patent (Law360)
• Lawmakers introduce bill to eliminate use of dogs in pharmaceutical testing (STAT)
• Sanofi Fails to Stop Fraud Suit Alleging Gifts for Prescriptions (Bloomberg)
• Transition for permitted indications for listed medicines ends 5 March 2021 (TGA)